Presentation TCT 2024 TCT 275: Clinical Outcomes in Acute Myocardial Infarction Cardiogenic Shock Patients Supported With Transvalvular Microaxial Pumps Presenter: Mark Anderson October 29, 2024
Presentation TCT 2024 TCT 279: Impacts of Hospital Volume and Patient-Hospital Distances on Outcomes of Patients Undergoing Percutaneous Microaxial Ventricular Assist Devices for Cardiogenic Shock Presenter: Atsuyuki Watanabe October 29, 2024
Presentation TCT 2024 TCT 268: Comparison of In-Hospital Outcomes and Patterns of Mechanical Circulatory Support for Patients With Cardiogenic Shock Transferred for Impella Support vs Those With In-House Support Presenter: Karnav Modi October 29, 2024
Presentation TCT 2024 TCT 270: Contemporary Use of Mechanical Circulatory Support for the Treatment of Acute Myocardial Infarction Cardiogenic Shock (AMI-CS): Insights From the BMC2 Registry Presenter: Eric Cantey October 29, 2024
Presentation TCT 2024 TCT 272: DANGER Shock Trial Versus Real-World Use of Microaxial Flow Pump in STEMI-Related Cardiogenic Shock Presenter: Jack Jnani October 29, 2024
Presentation TCT 2024 TCT 273: DanGer Shock-Like Profile Predicts the Outcome of Patients With ST-Elevation Myocardial Infarction Related Cardiogenic Shock Presenter: Norman Mangner October 29, 2024
Presentation TCT 2024 TCT 269: Insights From the Danger-SHOCK and ECLS-Shock Trials: A Comparative Analysis Presenter: Giuseppe Tarantini October 29, 2024
Presentation TCT 2024 Results of DanGer Shock: Risks and Benefits of MCS for Cardiogenic Shock Put Into Perspective Presenter: Jacob Moeller October 29, 2024
Presentation TCT 2024 Ways in Which DanGer Will and Will Not Influence Clinical Practice in the EU Presenter: Jose Henriques October 29, 2024
Presentation TCT 2024 A Mandate to Generate Evidence for the Use of Temporary Support Devices in Decompensated Chronic Heart Failure Shock Presenter: Jane Wilcox October 29, 2024
Presentation TCT 2024 Ways in which DanGer Will and Will Not Influence Clinical Practice in the US Presenter: David Morrow October 29, 2024
Presentation TCT 2024 TCT 267: Impact of Microaxial Flow Pump on Central Hemodynamics and Use of Vasoactive Drugs During Intensive Care After Infarct-Related Cardiogenic Shock: A Secondary Analysis of the Danger Shock Trial Presenter: Nanna Louise Junker Udesen October 29, 2024
Presentation TCT 2024 TCT 262: Clinical and Hemodynamic Predictors of Stabilization and Associated Complications in Cardiogenic Shock Patients Supported With Impella 5.5 Presenter: Shashank Sinha October 29, 2024
Presentation TCT 2024 TCT 263: Prospective Validation of the MIRACLE2 Score for Early Neurological Stratification After Out-of-Hospital-Cardiac-Arrest: The GLOBAL-MIRACLE Registry Presenter: Nilesh Pareek October 29, 2024
Presentation TCT 2024 TCT 266: Trends and Outcomes With Mechanical Circulatory Support Among Patients With Mechanical Complications of Acute Myocardial Infarction: A Nationwide Analysis Presenter: Ahmed Younes October 29, 2024
Presentation TCT 2024 TCT 264: Improving Risk Stratification of SCAI Stages of Cardiogenic Shock With Machine Learning-Based Phenotyping Presenter: Elric Zweck October 29, 2024
Presentation TCT 2024 TCT 265: Bleedings Related to Use of Microaxial Flow Pump in Cardiogenic Shock: A Secondary Analysis of Danger Shock Presenter: Rikke Sørensen October 29, 2024
Presentation TCT 2024 Case Presentation: Cardiogenic Shock in a Patient With Non-ischemic Cardiomyopathy Presenter: Ann Gage October 29, 2024
Presentation TCT 2024 TCT 806: Age-Based Temporal Trends in Outcomes of Cardiogenic Shock in Patients With Acute Myocardial Infarction Presenter: Muddasir Ashraf October 29, 2024
Presentation TCT 2024 TCT 808: Association Between In-Hospital Mortality and Gender in ST Elevation Myocardial Infarction Patients With Cardiogenic Shock Presenter: Narumi Taninobu October 29, 2024